A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models

被引:67
作者
Maruggi, Giulietta [1 ]
Mallett, Corey P. [1 ]
Westerbeck, Jason W. [1 ]
Chen, Tiffany [1 ]
Lofano, Giuseppe [1 ]
Friedrich, Kristian [1 ]
Qu, Lin [1 ,8 ]
Sun, Jennifer Tong [1 ]
McAuliffe, Josie [1 ]
Kanitkar, Amey [1 ]
Arrildt, Kathryn T. [1 ,9 ]
Wang, Kai-Fen [1 ]
McBee, Ian [1 ,10 ]
McCoy, Deborah [3 ]
Terry, Rebecca [2 ]
Rowles, Alison [2 ]
Abrahim, Maia Araujo [4 ]
Ringenberg, Michael A. [3 ]
Gains, Malcolm J. [4 ]
Spickler, Catherine [4 ]
Xie, Xuping [7 ]
Zou, Jing [7 ]
Shi, Pei-Yong [7 ]
Dutt, Taru [5 ]
Henao-Tamayo, Marcela [5 ]
Ragan, Izabela [6 ]
Bowen, Richard A. [6 ]
Johnson, Russell [1 ,11 ]
Nuti, Sandra [1 ]
Luisi, Kate [1 ]
Ulmer, Jeffrey B. [1 ]
Steff, Ann-Muriel [1 ]
Jalah, Rashmi [1 ]
Bertholet, Sylvie [1 ]
Stokes, Alan H. [3 ]
Yu, Dong [1 ,12 ]
机构
[1] GSK, Rockville, MD 20850 USA
[2] GSK, Ware SG12 ODP, Herts, England
[3] GSK, Upper Providence, PA 19426 USA
[4] Charles River Labs, Laval, PQ H7V 4B3, Canada
[5] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80521 USA
[6] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80521 USA
[7] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA
[8] Venatorx Pharmaceut Inc, Malvern, PA USA
[9] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA
[10] Novavax, Gaithersburg, MD 20878 USA
[11] RVAC Med, Medford, MA 02155 USA
[12] Dynavax Technol, Emeryville, CA 94608 USA
关键词
SEX-DIFFERENCES; SINGLE; DELIVERY; MEMORY;
D O I
10.1016/j.ymthe.2022.01.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
RNA vaccines have demonstrated efficacy against SARS-CoV-2 in humans, and the technology is being leveraged for rapid emergency response. In this report, we assessed immunogenicity and, for the first time, toxicity, biodistribution, and protective efficacy in preclinical models of a two-dose self amplifying messenger RNA (SAM) vaccine, encoding a prefusion-stabilized spike antigen of SARS-CoV-2 Wuhan-Hu-1 strain and delivered by lipid nanoparticles (LNPs). In mice, one immunization with the SAM vaccine elicited a robust spike-specific antibody response, which was further boosted by a second immunization, and effectively neutralized the matched SARS-CoV-2 Wuhan strain as well as B.1.1.7 (Alpha), B.1.351 (Beta) and B.1.617.2 (Delta) variants. High frequencies of spike-specific germinal center B, Th0/Th1 CD4, and CD8 T cell responses were observed in mice. Local tolerance, potential systemic toxicity, and biodistribution of the vaccine were characterized in rats. In hamsters, the vaccine candidate was well-tolerated, markedly reduced viral load in the upper and lower airways, and protected animals against disease in a dose-dependent manner, with no evidence of disease enhancement following SARS-CoV-2 challenge. Therefore, the SARSCoV-2 SAM (LNP) vaccine candidate has a favorable safety profile, elicits robust protective immune responses against multiple SARS-CoV-2 variants, and has been advanced to phase 1 clinical evaluation (NCT04758962).
引用
收藏
页码:1897 / 1912
页数:16
相关论文
共 49 条
[1]   Characterization of equine and other vertebrate TLR3, TLR7, and TLR8 genes [J].
Astakhova, Natalia M. ;
Perelygin, Andrey A. ;
Zharkikh, Andrey A. ;
Lear, Teri L. ;
Coleman, Stephen J. ;
MacLeod, James N. ;
Brinton, Margo A. .
IMMUNOGENETICS, 2009, 61 (07) :529-539
[2]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[3]   A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response [J].
Bolles, Meagan ;
Deming, Damon ;
Long, Kristin ;
Agnihothram, Sudhakar ;
Whitmore, Alan ;
Ferris, Martin ;
Funkhouser, William ;
Gralinski, Lisa ;
Totura, Allison ;
Heise, Mark ;
Baric, Ralph S. .
JOURNAL OF VIROLOGY, 2011, 85 (23) :12201-12215
[4]   Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility [J].
Chan, Jasper Fuk-Woo ;
Zhang, Anna Jinxia ;
Yuan, Shuofeng ;
Poon, Vincent Kwok-Man ;
Chan, Chris Chung-Sing ;
Lee, Andrew Chak-Yiu ;
Chan, Wan-Mui ;
Fan, Zhimeng ;
Tsoi, Hoi-Wah ;
Wen, Lei ;
Liang, Ronghui ;
Cao, Jianli ;
Chen, Yanxia ;
Tang, Kaiming ;
Luo, Cuiting ;
Cai, Jian-Piao ;
Kok, Kin-Hang ;
Chu, Hin ;
Chan, Kwok-Hung ;
Sridhar, Siddharth ;
Chen, Zhiwei ;
Chen, Honglin ;
To, Kelvin Kai-Wang ;
Yuen, Kwok-Yung .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) :2428-2446
[5]   Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection [J].
Channappanavar, Rudragouda ;
Fett, Craig ;
Zhao, Jincun ;
Meyerholz, David K. ;
Perlman, Stanley .
JOURNAL OF VIROLOGY, 2014, 88 (19) :11034-11044
[6]   A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice [J].
de Alwis, Ruklanthi ;
Gan, Esther S. ;
Chen, Shiwei ;
Leong, Yan Shan ;
Tan, Hwee Cheng ;
Zhang, Summer L. ;
Yau, Clement ;
Low, Jenny G. H. ;
Kalimuddin, Shirin ;
Matsuda, Daiki ;
Allen, Elizabeth C. ;
Hartman, Paula ;
Park, Kyoung-Joo Jenny ;
Alayyoubi, Maher ;
Bhaskaran, Hari ;
Dukanovic, Adrian ;
Bao, Yanjie ;
Clemente, Brenda ;
Vega, Jerel ;
Roberts, Scott ;
Gonzalez, Jose A. ;
Sablad, Marciano ;
Yelin, Rodrigo ;
Taylor, Wendy ;
Tachikawa, Kiyoshi ;
Parker, Suezanne ;
Karmali, Priya ;
Davis, Jared ;
Sullivan, Brian M. ;
Sullivan, Sean M. ;
Hughes, Steve G. ;
Chivukula, Pad ;
Ooi, Eng Eong .
MOLECULAR THERAPY, 2021, 29 (06) :1970-1983
[7]  
EMA-CPMP, 1997, CPMPSWP46595 EMA
[8]   An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates [J].
Erasmus, Jesse H. ;
Khandhar, Amit P. ;
O'Connor, Megan A. ;
Walls, Alexandra C. ;
Hemann, Emily A. ;
Murapa, Patience ;
Archer, Jacob ;
Leventhal, Shanna ;
Fuller, James T. ;
Lewis, Thomas B. ;
Draves, Kevin E. ;
Randall, Samantha ;
Guerriero, Kathryn A. ;
Duthie, Malcolm S. ;
Carter, Darrick ;
Reed, Steven G. ;
Hawman, David W. ;
Feldmann, Heinz ;
Gale, Michael, Jr. ;
Veesler, David ;
Berglund, Peter ;
Fuller, Deborah Heydenburg .
SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (555)
[9]   A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika [J].
Erasmus, Jesse H. ;
Khandhar, Amit P. ;
Guderian, Jeff ;
Granger, Brian ;
Archer, Jacob ;
Archer, Michelle ;
Gage, Emily ;
Fuerte-Stone, Jasmine ;
Larson, Elise ;
Lin, Susan ;
Kramer, Ryan ;
Coler, Rhea N. ;
Fox, Christopher B. ;
Stinchcomb, Dan T. ;
Reed, Steven G. ;
Van Hoeven, Neal .
MOLECULAR THERAPY, 2018, 26 (10) :2507-2522
[10]  
FDA Office of the Commissioner, 2021, FDA APPR 1 COVID 19